| |
| |
|
| Insider
Information: |
Provost Miriam |
| Relationship: |
|
| City: |
Andover |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,348 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,971,733 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,348 |
|
|
| Total
Value |
$2,971,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Transmedics Group, Inc. |
TMDX |
|
2023-12-15 |
23,348 |
2020-12-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,785 |
23,348 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-12-13 |
4 |
S |
$75.10 |
$309,562 |
D/D |
(4,122) |
25,133 |
0 |
% |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-12-13 |
4 |
OE |
$16.14 |
$252,914 |
D/D |
5,644 |
27,540 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-08-31 |
4 |
S |
$66.52 |
$180,136 |
D/D |
(2,708) |
23,611 |
0 |
% |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-08-31 |
4 |
OE |
$3.22 |
$147,857 |
D/D |
5,480 |
26,319 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2023-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,685 |
20,839 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2022-12-13 |
4 |
S |
$62.24 |
$269,797 |
D/D |
(4,315) |
15,154 |
0 |
% |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2022-12-13 |
4 |
OE |
$38.46 |
$227,606 |
D/D |
5,918 |
19,469 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2022-12-09 |
4 |
S |
$59.00 |
$213,167 |
D/D |
(3,613) |
13,551 |
0 |
% |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2022-12-09 |
4 |
OE |
$16.14 |
$171,500 |
D/D |
5,126 |
14,118 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP, Global Regulatory Affairs |
• – – |
2022-09-02 |
4 |
OE |
$3.22 |
$8,372 |
D/D |
2,600 |
12,038 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP of US Regulatory & FDA Rel. |
• – – |
2021-12-23 |
4 |
OE |
$3.22 |
$2,846 |
D/D |
884 |
9,438 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP of US Regulatory & FDA Rel. |
• – – |
2021-09-15 |
4 |
S |
$31.34 |
$121,505 |
D/D |
(3,877) |
8,554 |
0 |
% |
|
| TMDX |
Transmedics Group, Inc. |
VP of US Regulatory & FDA Rel. |
• – – |
2021-09-15 |
4 |
OE |
$16.14 |
$90,788 |
D/D |
5,625 |
12,431 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP of US Regulatory & FDA Rel. |
• – – |
2021-07-30 |
4 |
OE |
$3.22 |
$7,103 |
D/D |
2,206 |
6,806 |
0 |
- |
|
| TMDX |
Transmedics Group, Inc. |
VP of US Regulatory & FDA Rel. |
• – – |
2020-12-11 |
4 |
OE |
$3.22 |
$14,812 |
D/D |
4,600 |
4,600 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
